Daiwa Securities Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-272
| Closed | -$4K | – | 1379 |
|
|
2024
Q1 | $4K | Hold |
272
| – | – | ﹤0.01% | 1230 |
|
|
2023
Q4 | $4K | Hold |
272
| – | – | ﹤0.01% | 1235 |
|
|
2023
Q3 | $3K | Hold |
272
| – | – | ﹤0.01% | 1205 |
|
|
2023
Q2 | $4K | Hold |
272
| – | – | ﹤0.01% | 1207 |
|
|
2023
Q1 | $4K | Hold |
272
| – | – | ﹤0.01% | 1170 |
|
|
2022
Q4 | $4K | Buy |
272
+73
| +37% | +$1.19K | ﹤0.01% | 1175 |
|
|
2022
Q3 | $4K | Hold |
199
| – | – | ﹤0.01% | 1184 |
|
|
2022
Q2 | $3K | Hold |
199
| – | – | ﹤0.01% | 1213 |
|
|
2022
Q1 | $2K | Hold |
199
| – | – | ﹤0.01% | 1279 |
|
|
2021
Q4 | $2K | Hold |
199
| – | – | ﹤0.01% | 1313 |
|
|
2021
Q3 | $7K | Buy |
199
+92
| +86% | +$2.94K | ﹤0.01% | 1163 |
|
|
2021
Q2 | $4K | Hold |
107
| – | – | ﹤0.01% | 1098 |
|
|
2021
Q1 | $5K | Hold |
107
| – | – | ﹤0.01% | 1081 |
|
|
2020
Q4 | $6K | Sell |
107
-211
| -66% | -$12.5K | ﹤0.01% | 1053 |
|
|
2020
Q3 | $16K | Buy |
318
+16
| +5% | +$784 | ﹤0.01% | 1012 |
|
|
2020
Q2 | $12K | Hold |
302
| – | – | ﹤0.01% | 1058 |
|
|
2020
Q1 | $12K | Buy |
302
+14
| +5% | +$777 | ﹤0.01% | 1049 |
|
|
2019
Q4 | $18K | Sell |
288
-24
| -8% | -$1.14K | ﹤0.01% | 1021 |
|
|
2019
Q3 | $11K | Buy |
312
+72
| +30% | +$2.13K | ﹤0.01% | 1029 |
|
|
2019
Q2 | $5K | Hold |
240
| – | – | ﹤0.01% | 1111 |
|
|
2019
Q1 | $6K | Sell |
240
-90
| -27% | -$2.36K | ﹤0.01% | 1073 |
|
|
2018
Q4 | $7K | Buy |
+330
| New | +$8.11K | ﹤0.01% | 1032 |
|
Other funds holding DCPH
Daiwa Securities Group's DCPH Position: Q2 2024 in Review
Daiwa Securities Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 272 shares — an estimated $4K sold.
Daiwa Securities Group first reported a position in DCPH in Q4 2018 and held it in 22 quarters. The position peaked at $18K in Q4 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Daiwa Securities Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Daiwa Securities Group sold 272 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $4K.
- Daiwa Securities Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 22 quarters.
- Daiwa Securities Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $18K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Daiwa Securities Group's 13F filing for Q2 2024, filed 7 Aug 2024.